PMC:6640909 / 83082-83656
Annnotations
TEST0
{"project":"TEST0","denotations":[{"id":"31100109-188-195-7634","span":{"begin":188,"end":191},"obj":"[\"28365175\"]"},{"id":"31100109-193-200-7635","span":{"begin":193,"end":196},"obj":"[\"24002006\"]"},{"id":"31100109-198-205-7636","span":{"begin":198,"end":201},"obj":"[\"27009673\"]"},{"id":"31100109-235-242-7637","span":{"begin":288,"end":291},"obj":"[\"28365175\"]"},{"id":"31100109-232-239-7638","span":{"begin":298,"end":301},"obj":"[\"25612114\"]"},{"id":"31100109-232-239-7639","span":{"begin":303,"end":306},"obj":"[\"26776864\"]"},{"id":"31100109-233-240-7640","span":{"begin":308,"end":311},"obj":"[\"27009673\"]"},{"id":"31100109-126-133-7641","span":{"begin":440,"end":443},"obj":"[\"19920051\"]"},{"id":"31100109-108-115-7642","span":{"begin":554,"end":557},"obj":"[\"28365175\"]"},{"id":"31100109-118-125-7643","span":{"begin":564,"end":567},"obj":"[\"27056612\"]"},{"id":"31100109-123-130-7644","span":{"begin":569,"end":572},"obj":"[\"27009673\"]"}],"text":"In paediatric patients with a body surface area \u003e1.2 m2 requiring MCS, the use of an implantable CF-LVAD is feasible because results are non-inferior to those with extracorporeal devices [275, 289, 290], and discharge from the hospital is possible, resulting in a better quality of life [275, 277, 284, 285, 290]. In adults, CF-VADs have improved survival and greater freedom from stroke and device failure compared with pulsatile devices [147]. This result seems to be true also for paediatric patients with a body surface area \u003e1.2 m2 and without CHD [275, 277, 279, 290]."}
MyTest
{"project":"MyTest","denotations":[{"id":"31100109-28365175-28905694","span":{"begin":188,"end":191},"obj":"28365175"},{"id":"31100109-24002006-28905695","span":{"begin":193,"end":196},"obj":"24002006"},{"id":"31100109-27009673-28905696","span":{"begin":198,"end":201},"obj":"27009673"},{"id":"31100109-28365175-28905697","span":{"begin":288,"end":291},"obj":"28365175"},{"id":"31100109-25612114-28905698","span":{"begin":298,"end":301},"obj":"25612114"},{"id":"31100109-26776864-28905699","span":{"begin":303,"end":306},"obj":"26776864"},{"id":"31100109-27009673-28905700","span":{"begin":308,"end":311},"obj":"27009673"},{"id":"31100109-19920051-28905701","span":{"begin":440,"end":443},"obj":"19920051"},{"id":"31100109-28365175-28905702","span":{"begin":554,"end":557},"obj":"28365175"},{"id":"31100109-27056612-28905703","span":{"begin":564,"end":567},"obj":"27056612"},{"id":"31100109-27009673-28905704","span":{"begin":569,"end":572},"obj":"27009673"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"In paediatric patients with a body surface area \u003e1.2 m2 requiring MCS, the use of an implantable CF-LVAD is feasible because results are non-inferior to those with extracorporeal devices [275, 289, 290], and discharge from the hospital is possible, resulting in a better quality of life [275, 277, 284, 285, 290]. In adults, CF-VADs have improved survival and greater freedom from stroke and device failure compared with pulsatile devices [147]. This result seems to be true also for paediatric patients with a body surface area \u003e1.2 m2 and without CHD [275, 277, 279, 290]."}
0_colil
{"project":"0_colil","denotations":[{"id":"31100109-28365175-7634","span":{"begin":188,"end":191},"obj":"28365175"},{"id":"31100109-24002006-7635","span":{"begin":193,"end":196},"obj":"24002006"},{"id":"31100109-27009673-7636","span":{"begin":198,"end":201},"obj":"27009673"},{"id":"31100109-28365175-7637","span":{"begin":288,"end":291},"obj":"28365175"},{"id":"31100109-25612114-7638","span":{"begin":298,"end":301},"obj":"25612114"},{"id":"31100109-26776864-7639","span":{"begin":303,"end":306},"obj":"26776864"},{"id":"31100109-27009673-7640","span":{"begin":308,"end":311},"obj":"27009673"},{"id":"31100109-19920051-7641","span":{"begin":440,"end":443},"obj":"19920051"},{"id":"31100109-28365175-7642","span":{"begin":554,"end":557},"obj":"28365175"},{"id":"31100109-27056612-7643","span":{"begin":564,"end":567},"obj":"27056612"},{"id":"31100109-27009673-7644","span":{"begin":569,"end":572},"obj":"27009673"}],"text":"In paediatric patients with a body surface area \u003e1.2 m2 requiring MCS, the use of an implantable CF-LVAD is feasible because results are non-inferior to those with extracorporeal devices [275, 289, 290], and discharge from the hospital is possible, resulting in a better quality of life [275, 277, 284, 285, 290]. In adults, CF-VADs have improved survival and greater freedom from stroke and device failure compared with pulsatile devices [147]. This result seems to be true also for paediatric patients with a body surface area \u003e1.2 m2 and without CHD [275, 277, 279, 290]."}
2_test
{"project":"2_test","denotations":[{"id":"31100109-28365175-28905694","span":{"begin":188,"end":191},"obj":"28365175"},{"id":"31100109-24002006-28905695","span":{"begin":193,"end":196},"obj":"24002006"},{"id":"31100109-27009673-28905696","span":{"begin":198,"end":201},"obj":"27009673"},{"id":"31100109-28365175-28905697","span":{"begin":288,"end":291},"obj":"28365175"},{"id":"31100109-25612114-28905698","span":{"begin":298,"end":301},"obj":"25612114"},{"id":"31100109-26776864-28905699","span":{"begin":303,"end":306},"obj":"26776864"},{"id":"31100109-27009673-28905700","span":{"begin":308,"end":311},"obj":"27009673"},{"id":"31100109-19920051-28905701","span":{"begin":440,"end":443},"obj":"19920051"},{"id":"31100109-28365175-28905702","span":{"begin":554,"end":557},"obj":"28365175"},{"id":"31100109-27056612-28905703","span":{"begin":564,"end":567},"obj":"27056612"},{"id":"31100109-27009673-28905704","span":{"begin":569,"end":572},"obj":"27009673"}],"text":"In paediatric patients with a body surface area \u003e1.2 m2 requiring MCS, the use of an implantable CF-LVAD is feasible because results are non-inferior to those with extracorporeal devices [275, 289, 290], and discharge from the hospital is possible, resulting in a better quality of life [275, 277, 284, 285, 290]. In adults, CF-VADs have improved survival and greater freedom from stroke and device failure compared with pulsatile devices [147]. This result seems to be true also for paediatric patients with a body surface area \u003e1.2 m2 and without CHD [275, 277, 279, 290]."}